'Hiring scientists wasn't on my roadmap': Andy Gomarsall on N2S expansion as he joins CRN Tech Impact judging panel
His Bury St Edmunds-based firm, N2S, has increased headcount from 60 to 83 during lockdown and is now on the hunt for scientists to help accelerate its bio-tech strategy. Using bioleaching techniques, N2S is breeding bacteria to extract gold and other rare metals from printed circuit boards, which Gomarsall said make up to 70 to 90 per cent of the embodied carbon in technology. CRN visited its facility last Spring. Having recently taken on two new investors, Gomarsall said N2S is close to reaching its goal of proving the technique end to end. "We need more scientists, which is exciting," h...